Skip navigation

Effective Legal Strategies to Negotiate M&A and Licensing Deals, Promote Pipeline Growth and Deliver Value to Stakeholders

October 26-28, 2016
  • Cambridge, MA

CBI's 2nd Annual Life Sciences Summit on M&A and Strategic Alliances delivers an in-depth educational and networking event for in-house counsel and private practice life sciences lawyers focused on legal strategies for life sciences alliances, collaborations and mergers.

2016 is shaping up to be another banner year for life sciences mergers and alliances. Continued pricing pressures along with the scarcity of products have made valuations and strong legal deal-making tactics critical to closing successful transactions to maximize pipeline growth – Don’t miss this unique opportunity to hear from leading M&A and collaboration experts on their latest successes and lessons learned.

Attend this event and learn cutting-edge insights and tactics focused on IPO industry trends, collaboration agreements, technology transfer, due diligence practices, transaction structuring, taxation best practices, IP valuation and antitrust strategies.

Chairperson
Keynote Speaker

Luba Greenwood
Vice President, Global M&A
and Business Development
F. Hoffmann-La Roche Ltd, Diagnostics

David Lucchino
Co-Founder & CEO
Frequency Therapeutics, Inc.

JOIN LIFE SCIENCES M&A, LICENSING AND COLLABORATION LEADERS IN CAMBRIDGE TO EXPLORE THE LATEST STRATEGIES INCLUDING:

CLE
Credits Pending Approval

  • Licensing Agreements—
    Drafting Tactics for Challenging Terms
  • Business Drivers and Deal Making—
    Analyzing Commercial Factors During Negotiations
  • Current State of the IPO Market —
    Impact on Life Sciences M&A and Licensing Partnerships and
    Other Transactional Challenges
  • Contingent Transactions—
    Leveraging Different Deal Structures to Balance Risk and Reward
  • Gene Therapy Deal Case Studies—
    Lessons Learned
  • Due Diligence—
    Ensuring FCPA Compliance by Third Parties
  • Intellectual Property—
    Assessing the Strength of a Target’s Portfolio
  • Cross-Border Transactions—
    Exploring FCPA Pitfalls Pre- and Post-Deal Signing
  • Antitrust Checklist—
    Coordinating Global Reporting Requirements
  • Digital Health Deals—
    Drafting Best Practices for Technology Transfer Agreements

FEATURED INDUSTRY PERSPECTIVES

Choate Covington F. Hoffmann-La Roche Ltd, Diagnostics
Faber Daeufer & Itrato Frequency Therapeutics, Inc.
Goodwin Procter LLP Heliae Development, LLC Hogan Lovells US LLP
Johnson & Johnson Innovation Center Medtronic, Inc. Nutter

October 26-27, 2016 Courtyard Boston Cambridge, MA